genia tagger: 181('shrna', 19)
('cd25', 11)
('collagenase', 2)
('effector', 7)
('ccl28', 4)
('hpai-xhoi', 2)
('non\\-treg\\.', 4)
('human', 58)
('foxp3gfp\\+', 2)
('ccl22', 4)
('mice', 87)
('ccl27', 4)
('scr', 14)
('\\?', 63)
('ccr10', 2)
('receptors', 8)
('monocytes', 2)
('lymphocytes', 16)
('\\/', 46)
('population', 8)
('suppressor', 4)
('endogenous', 2)
('\\(', 260)
('\\)', 260)
('foxp3', 53)
('psicor-puro', 4)
('tak\\-779\\.', 6)
('pure', 2)
('hiv', 6)
('cd4\\+foxp3', 24)
('non-fluorescent', 2)
('ccr5\\+\\.', 2)
('cd4', 67)
('non-metastatic', 2)
('chemokines', 7)
('b', 574)
('breast', 4)
('pbmc', 4)
('intranuclear', 4)
('cd8', 2)
('secondary', 4)
('ccl2', 16)
('ccl3', 16)
('and', 313)
('ccl1', 6)
('ccl4', 14)
('ccl5', 145)
('anti-rabbit', 2)
('51', 8)
('n\\=13', 4)
('53', 4)
('fibroblasts', 2)
('vector', 10)
('t', 4762)
('mrna', 2)
('ccl5\\.', 10)
('epcam', 14)
('mesenchymal', 2)
('mo', 499)
('4-fold', 4)
('psicor-gfp', 4)
('proteins', 2)
('peripheral', 8)
('humans', 6)
('68', 2)
('phosphoribosyl-transferase', 2)
('\xe2\x80\x9cccl5lo', 4)
('cxcl12', 2)
('elisa', 14)
('cxcr3', 6)
('pan02', 79)
('ccl17', 2)
('sites', 8)
('cell', 172)
('3', 171)
('chemokine-binding', 2)
('7', 152)
('nln', 8)
('myeloid-derived', 2)
('cd4\\+', 51)
('macrophages', 4)
('population\\.', 2)
('stem', 29)
('quencher', 2)
('regulatory', 18)
('mononuclear', 2)
('106', 2)
('anti-human', 10)
('pancreatic', 83)
('tumor-associated', 11)
('cd25\\+', 7)
('37', 6)
('5tmm', 2)
('tumor', 316)
('ccr1', 4)
('ccr4', 6)
('ccr5', 227)
('647', 2)
('irradiated', 2)
('gene', 32)
('antibody', 4)
('ccr5\\+', 28)
('cancer', 36)
('tak-779', 41)
('c0cl5', 2)
('endothelial', 2)
('anti-cd3', 4)
('receptor', 15)
('tumors', 44)
('66', 2)
('wild-type', 12)
('cells\\.', 12)
('total', 4)
('\xc3\x97', 2)
('g\\/ml', 14)
('tdln', 20)
('cxcl8', 2)
('dnase', 2)
('2', 216)
('adenocarcinoma', 61)
('6', 76)
('malignant', 2)
('splenocytes', 2)
('monoclonal', 2)
('c', 3417)
('infection', 12)
('vcci', 2)
('\\.', 465)
('ctcctggaagatggtgatgg', 3)
('hypoxanthine-guanine', 2)
('line', 22)
('ligands', 35)
('malignancy\\.', 2)
('transduced', 6)
('subsets', 2)
('type', 28)
('cells', 128)
('treg', 232)
('collagen-induced', 2)
('wild', 16)
('control', 29)
('rag', 10)
('donkey', 6)
('ccr5\\.', 11)
('figure', 68)
('thy1\\.2\\+', 6)
('lines', 4)
('site', 12)
('surface', 4)
('tdlns', 4)
('rat', 131)
('protein', 4)
('thy1\\.1\\+', 4)
('pan02\xe2\x80\x9d', 4)
('increased', 20)
('49', 10)
('stromal', 2)
('il-12', 4)
('cytometry', 8)
('b16', 2)
('epcam-negative', 2)
('other', 56)
('5', 520)
('cd4\\+cd25\\+foxp3\\+', 1)
('\xe2\x80\x93', 38)
('0\\.1mg\\/ml', 2)
('viral', 16)
('arthritis', 2)
('000', 14)
('blood', 12)
('probes', 6)
('a', 4105)
('antibodies', 6)
('mdsc', 4)
('spleen', 26)
('adenocarcinoma\\.', 10)
('flow', 8)
('myeloma', 2)
('chemokine', 34)
('mast', 4)
('model', 32)


spacy + metamap: 528('thermal cycler', 2)
('magnetic', 4)
('ccl28', 4)
('pancreas cancer', 6)
('debris', 2)
('primer', 9)
('ccl27', 4)
('scr', 14)
('synthetic', 4)
('particles', 2)
('ccl2 signaling', 2)
('pancreatic ductal adenocarcinoma', 2)
('environment', 39)
('program', 2)
('present', 13)
('monocytes', 2)
('endogenous', 2)
('division', 2)
('assay', 6)
('phenotypes', 2)
('blockade', 11)
('cellular', 6)
('difference', 16)
('minute', 8)
('school', 2)
('c57bl\\/6', 12)
('large', 8)
('homeostatic', 2)
('vector', 10)
('small', 15)
('ccl5 gene', 4)
('accumulation', 4)
('1 minute', 2)
('findings', 2)
('ovarian cancer', 2)
('consistent', 2)
('recruitment', 7)
('rate', 34)
('knock-in', 2)
('pancreatic cancer', 9)
('elisa', 14)
('ccl22', 4)
('filtration', 4)
('section', 6)
('availability', 2)
('cell', 172)
('malignant cells', 2)
('nine', 4)
('method', 7)
('contrast', 6)
('colorectal cancer', 2)
('reporter', 2)
('implantable', 2)
('genes', 4)
('48 hours', 2)
('groups', 10)
('pancreas', 20)
('frozen specimen', 4)
('healthy', 14)
('inflammatory response', 4)
('study', 21)
('vectors', 2)
('dosage', 2)
('cessation', 4)
('reagents', 2)
('gene', 32)
('studies', 10)
('immune evasion', 5)
('sample size', 4)
('decrease', 4)
('infiltrating', 20)
('total', 4)
('g\\/ml', 14)
('suspensions', 2)
('use', 55)
('positive', 16)
('two', 10)
('next', 12)
('vehicle', 12)
('normal pancreas', 10)
('splenocytes', 2)
('more', 18)
('0\\%', 20)
('trait', 2)
('infection', 12)
('disruption', 9)
('investigation', 2)
('rabbit', 6)
('cases', 10)
('animals', 2)
('ml', 16)
('mo', 499)
('cancer patient', 4)
('labeled', 2)
('desmoplastic', 4)
('three', 2)
('chemokine signaling pathway', 2)
('strategies', 2)
('inhibitor', 1)
('example', 2)
('10\\%', 4)
('control', 29)
('antagonists', 2)
('immune system', 2)
('cd4\\+\\ cell', 2)
('sample', 10)
('numbers', 8)
('breast cancer cell', 2)
('axis', 32)
('transduction', 6)
('redundancy', 4)
('discussion', 2)
('six', 6)
('feature', 2)
('delay', 2)
('immune', 9)
('post', 3)
('pure', 2)
('myeloid', 2)
('goat', 4)
('healthy volunteers', 14)
('derived', 2)
('tumor model', 3)
('modest', 2)
('fc', 2)
('blood', 12)
('data', 38)
('response', 6)
('m cell', 4)
('ablation', 2)
('t cells', 41)
('st', 341)
('30 minutes', 2)
('correlation', 2)
('peripheral blood mononuclear cell', 2)
('shrna', 19)
('pyran', 2)
('donors peripheral blood', 2)
('collagenase', 2)
('experiments', 6)
('committee', 4)
('staining', 20)
('priming', 2)
('group', 16)
('ligand', 37)
('prognosis', 2)
('pcr', 31)
('absence', 2)
('production', 21)
('pancreatic tumors', 4)
('suspension', 4)
('weeks', 12)
('suppressor', 4)
('foxp3', 53)
('non', 32)
('greater', 8)
('combination', 2)
('washington', 6)
('immune tolerance', 1)
('number', 14)
('reagent', 4)
('chemokines', 7)
('therapy', 10)
('effects', 4)
('compound', 2)
('not', 96)
('instructions', 6)
('ccl2', 16)
('ccl3', 16)
('ccl4', 14)
('ccl5', 145)
('university', 4)
('drop', 4)
('labeling', 2)
('mrna', 2)
('2h', 2)
('mean', 4)
('development', 4)
('generation', 4)
('small molecule', 2)
('gfp', 13)
('effector t cells', 5)
('leishmania major', 2)
('aids', 4)
('out', 6)
('20\\%', 6)
('research', 6)
('animal facility', 2)
('mediated', 16)
('medicine', 2)
('immunohistochemistry', 8)
('localization', 8)
('cancer research', 2)
('monoclonal antibodies', 2)
('mechanisms', 1)
('suppressor cells', 4)
('isotope', 2)
('standard', 2)
('specimen collection', 2)
('regulatory', 18)
('pancreatic', 83)
('local', 12)
('tumor growth', 28)
('r-', 57)
('cell lines', 4)
('disease model', 4)
('major', 4)
('strainer', 2)
('vitro', 14)
('frequently', 2)
('stage', 10)
('size', 10)
('little', 2)
('impairing', 2)
('ten', 14)
('lymph nodes', 14)
('prostate', 2)
('contact', 2)
('system', 27)
('approximately', 16)
('tumor regression', 2)
('master', 2)
('suppressive', 8)
('chemotherapy', 2)
('percentage', 10)
('lower', 4)
('nci', 2)
('part', 36)
('rtpcr', 12)
('signaling', 20)
('institution', 2)
('population', 8)
('relative', 4)
('target', 10)
('fold', 12)
('isolation', 2)
('regulatory t cell', 18)
('oligonucleotides', 2)
('patients', 30)
('similar', 16)
('result', 2)
('donkey', 6)
('systemic administration', 5)
('san', 8)
('disease progression', 2)
('mediators', 2)
('lentivirus', 6)
('rat', 131)
('further', 18)
('cell surface', 4)
('organs', 2)
('cell types', 4)
('il-12', 4)
('mechanism', 5)
('tumor inoculation', 4)
('note', 8)
('instance', 2)
('chemotaxis', 18)
('multiple', 4)
('normal', 26)
('buffer', 2)
('centrifugation', 2)
('most', 6)
('significant', 26)
('preliminary', 2)
('intrinsic', 4)
('probes', 6)
('spleen', 26)
('disease', 6)
('inguinal lymph node', 8)
('pancreatic cancers', 4)
('sigma', 4)
('phenomenon', 6)
('probe', 6)
('surgically', 8)
('ipsilateral', 4)
('lethal', 4)
('mice', 87)
('nln', 8)
('completion', 8)
('ratio', 61)
('knowledge', 2)
('only', 14)
('\\/ml', 16)
('plate', 2)
('peptide', 4)
('antagonism', 2)
('dependent', 9)
('overall', 4)
('cd4', 67)
('cxcr3', 6)
('procedures', 2)
('antagonist', 18)
('secondary', 4)
('rna expression', 2)
('organ', 8)
('tumors', 44)
('differential', 2)
('summary', 2)
('microscope', 4)
('epcam', 14)
('cycles', 4)
('ficoll', 2)
('reference', 2)
('t cell subsets', 2)
('humans', 6)
('detection', 2)
('individual', 6)
('migration', 36)
('puromycin', 2)
('endothelial cells', 2)
('arm', 2)
('subject', 2)
('tumor microenvironment', 37)
('subsequent', 10)
('circulating', 4)
('sites', 8)
('available', 2)
('statistically', 4)
('wa', 148)
('efficiency', 2)
('thy1', 10)
('reaction', 2)
('3\\+', 14)
('minutes', 6)
('pancreatic adenocarcinoma', 59)
('duplex', 2)
('ccr2', 2)
('ccr5', 227)
('context', 2)
('expression', 86)
('co', 272)
('cancer', 36)
('ccl5 production', 9)
('panel', 2)
('ct', 276)
('targeting', 1)
('intracellular', 4)
('splenic', 4)
('strategy', 3)
('reduction', 10)
('initiation', 4)
('1 mm', 2)
('interest', 2)
('cfse', 6)
('treatment', 23)
('cell fraction', 2)
('lymphoid', 4)
('representative', 4)
('demand', 2)
('ligands', 35)
('protocols', 4)
('applied', 6)
('novel', 3)
('frozen', 4)
('tumor-specific antigen', 2)
('receive', 2)
('ongoing', 2)
('2\\+', 6)
('aid', 8)
('tumor specimens', 2)
('concomitant', 2)
('prevalence', 45)
('tissue', 30)
('left thigh', 2)
('spleens', 2)
('tumorigenesis', 2)
('protein', 4)
('mouse', 23)
('80\\%', 4)
('different', 12)
('baseline', 4)
('ccr1', 4)
('chemokine receptor', 11)
('administration', 11)
('same', 16)
('plates', 2)
('mast cells', 2)
('week', 22)
('nih', 4)
('t reg', 2)
('effect', 33)
('kit', 2)
('levels', 9)
('quantitation', 2)
('immunofluorescence', 2)
('destruction', 1)
('metastatic tumor', 2)
('antibodies', 6)
('drain', 16)
('center', 2)
('well', 6)
('analysis', 2)
('compartments', 28)
('chemokine', 34)
('materials', 1)
('model', 32)
('clearance', 2)
('protocol', 6)
('less', 2)
('50\\%', 4)
('human', 58)
('useful', 4)
('mix', 2)
('irradiated', 2)
('ccr10', 2)
('myeloma cell', 2)
('r\\.', 8)
('5h', 2)
('lymphocytes', 16)
('murine', 24)
('resections', 2)
('increased', 20)
('magnetic bead separation', 2)
('organ donation', 2)
('injection', 4)
('72 hours', 2)
('inhibition', 8)
('five', 2)
('pbmc', 4)
('one week', 8)
('malignancy', 4)
('parasite', 2)
('specific', 11)
('supernatant', 4)
('lymphocytic infiltration', 2)
('immunosuppressive', 4)
('either', 5)
('dilution', 2)
('l-', 26)
('old', 14)
('teff', 6)
('sequence', 4)
('cell line', 12)
('growth', 38)
('intact', 6)
('breast carcinoma', 2)
('fibroblasts', 2)
('flow cytometry', 8)
('dense', 4)
('resected', 18)
('4 weeks', 4)
('depletion', 4)
('inflammation', 6)
('gene expression', 14)
('cd11b', 2)
('bd', 4)
('repository', 2)
('ccl17', 2)
('seconds', 2)
('10 minutes', 2)
('host', 2)
('fluorescent', 2)
('dct', 2)
('manufacturer', 8)
('tissue section', 4)
('tumor', 316)
('range', 8)
('systemic', 13)
('cancer stage', 2)
('histopaque', 4)
('curative', 2)
('block', 23)
('software', 4)
('hpai', 2)
('presence', 8)
('hyaluronidase', 2)
('image', 6)
('blood samples', 2)
('functional', 6)
('negative', 8)
('receptor', 15)
('t cell migration', 6)
('methods', 5)
('5 days', 4)
('vaccination', 2)
('hiv infection', 4)
('dnase', 2)
('low', 32)
('fraction', 2)
('secretion', 6)
('specimens', 16)
('function', 8)
('intratumoral', 4)
('medium', 2)
('complete', 8)
('secreted', 2)
('tumor-associated macrophage', 4)
('line', 22)
('4\\+', 51)
('type', 28)
('cells', 128)
('ccr5 signaling', 12)
('vivo', 10)
('frequency', 4)
('rnai', 4)
('mouse model', 10)
('piece', 2)
('inoculation', 6)
('display', 4)
('bearing', 6)
('associated', 13)
('contralateral', 4)
('universal', 2)
('al', 442)
('slowing', 4)
('evidence', 4)
('single', 2)
('anti-cd3 antibody', 4)
('laboratory', 2)
('graft', 2)
('cxcl12', 2)
('nm', 41)
('control groups', 6)
('niaid', 2)
('conclusion', 2)
('met', 23)
('models', 6)
('histopathologic type', 2)
('important', 14)
('suppression', 4)
('30 minute', 2)
('kinetics', 4)
('immunocompetent', 4)
('time', 18)
('fresh', 4)
('cd4\\+\\ cd25\\+\\ regulatory\\ t\\ cells', 2)
('4c', 4)


total: 641('thermal cycler', 2)
('duplex', 2)
('magnetic', 4)
('ccl28', 4)
('n\\=13', 4)
('debris', 2)
('4-fold', 4)
('ccl22', 4)
('ccl27', 4)
('scr', 14)
('synthetic', 4)
('particles', 2)
('ccl2 signaling', 2)
('pancreatic ductal adenocarcinoma', 2)
('environment', 39)
('program', 2)
('present', 13)
('monocytes', 2)
('endogenous', 2)
('division', 2)
('assay', 6)
('phenotypes', 2)
('blockade', 11)
('cellular', 6)
('specific', 11)
('difference', 16)
('minute', 8)
('school', 2)
('c57bl\\/6', 12)
('pancreas cancer', 6)
('large', 8)
('homeostatic', 2)
('vector', 10)
('ccl5\\.', 10)
('small', 15)
('ccl5 gene', 4)
('accumulation', 4)
('1 minute', 2)
('findings', 2)
('ovarian cancer', 2)
('consistent', 2)
('recruitment', 7)
('rate', 34)
('knock-in', 2)
('pancreatic cancer', 9)
('elisa', 14)
('primer', 9)
('filtration', 4)
('section', 6)
('macrophages', 4)
('availability', 2)
('cell', 172)
('chemokine-binding', 2)
('malignant cells', 2)
('nine', 4)
('method', 7)
('contrast', 6)
('colorectal cancer', 2)
('reporter', 2)
('g\\/ml', 14)
('implantable', 2)
('genes', 4)
('48 hours', 2)
('groups', 10)
('quencher', 2)
('106', 2)
('anti-human', 10)
('pancreas', 20)
('frozen specimen', 4)
('tumor-associated', 11)
('inflammatory response', 4)
('study', 21)
('vectors', 2)
('37', 6)
('dosage', 2)
('647', 2)
('cessation', 4)
('reagents', 2)
('gene', 32)
('studies', 10)
('control', 29)
('immune evasion', 5)
('sample size', 4)
('injection', 4)
('decrease', 4)
('infiltrating', 20)
('total', 4)
('post', 3)
('suspensions', 2)
('use', 55)
('cxcl8', 2)
('two', 10)
('next', 12)
('6', 76)
('normal pancreas', 10)
('splenocytes', 2)
('more', 18)
('0\\%', 20)
('trait', 2)
('infection', 12)
('disruption', 9)
('investigation', 2)
('rabbit', 6)
('cases', 10)
('animals', 2)
('ml', 16)
('mo', 499)
('cancer patient', 4)
('labeled', 2)
('desmoplastic', 4)
('three', 2)
('chemokine signaling pathway', 2)
('strategies', 2)
('inhibitor', 1)
('example', 2)
('10\\%', 4)
('ccr5\\+', 28)
('antagonists', 2)
('ccr5\\.', 11)
('figure', 68)
('immune system', 2)
('cd4\\+\\ cell', 2)
('sample', 10)
('numbers', 8)
('breast cancer cell', 2)
('peptide', 4)
('axis', 32)
('transduction', 6)
('redundancy', 4)
('discussion', 2)
('six', 6)
('feature', 2)
('delay', 2)
('immune', 9)
('pure', 2)
('myeloid', 2)
('goat', 4)
('healthy volunteers', 14)
('mesenchymal', 2)
('arthritis', 2)
('derived', 2)
('tumor model', 3)
('modest', 2)
('fc', 2)
('blood', 12)
('data', 38)
('response', 6)
('a', 4105)
('m cell', 4)
('adenocarcinoma\\.', 10)
('ablation', 2)
('lines', 4)
('st', 341)
('30 minutes', 2)
('correlation', 2)
('peripheral blood mononuclear cell', 2)
('shrna', 19)
('pyran', 2)
('donors peripheral blood', 2)
('collagenase', 2)
('hpai-xhoi', 2)
('non\\-treg\\.', 4)
('frequency', 4)
('committee', 4)
('foxp3gfp\\+', 2)
('staining', 20)
('priming', 2)
('group', 16)
('ligand', 37)
('prognosis', 2)
('pcr', 31)
('procedures', 2)
('absence', 2)
('production', 21)
('pancreatic tumors', 4)
('suspension', 4)
('weeks', 12)
('suppressor', 4)
('foxp3', 53)
('psicor-puro', 4)
('greater', 8)
('combination', 2)
('blood samples', 2)
('immune tolerance', 1)
('non-fluorescent', 2)
('number', 14)
('non-metastatic', 2)
('chemokines', 7)
('therapy', 10)
('effects', 4)
('compound', 2)
('not', 96)
('instructions', 6)
('ccl2', 16)
('ccl3', 16)
('ccl1', 6)
('ccl4', 14)
('ccl5', 145)
('university', 4)
('drop', 4)
('proteins', 2)
('labeling', 2)
('mrna', 2)
('2h', 2)
('mean', 4)
('week', 22)
('generation', 4)
('small molecule', 2)
('gfp', 13)
('\xe2\x80\x9cccl5lo', 4)
('leishmania major', 2)
('aids', 4)
('out', 6)
('20\\%', 6)
('research', 6)
('animal facility', 2)
('mediated', 16)
('7', 152)
('medicine', 2)
('myeloid-derived', 2)
('cd4\\+', 51)
('immunohistochemistry', 8)
('localization', 8)
('cancer research', 2)
('monoclonal antibodies', 2)
('population\\.', 2)
('mechanisms', 1)
('suppressor cells', 4)
('isotope', 2)
('standard', 2)
('specimen collection', 2)
('regulatory', 18)
('mononuclear', 2)
('pancreatic', 83)
('local', 12)
('000', 14)
('tumor growth', 28)
('r-', 57)
('cell lines', 4)
('disease model', 4)
('major', 4)
('strainer', 2)
('c0cl5', 2)
('vitro', 14)
('frequently', 2)
('wild-type', 12)
('\xc3\x97', 2)
('stage', 10)
('size', 10)
('little', 2)
('impairing', 2)
('ten', 14)
('lymph nodes', 14)
('prostate', 2)
('contact', 2)
('system', 27)
('approximately', 16)
('tumor regression', 2)
('2', 216)
('master', 2)
('suppressive', 8)
('chemotherapy', 2)
('percentage', 10)
('lower', 4)
('nci', 2)
('part', 36)
('rtpcr', 12)
('signaling', 20)
('institution', 2)
('population', 8)
('relative', 4)
('b', 574)
('target', 10)
('fold', 12)
('isolation', 2)
('regulatory t cell', 18)
('oligonucleotides', 2)
('treg', 232)
('patients', 30)
('similar', 16)
('result', 2)
('and', 313)
('rag', 10)
('donkey', 6)
('systemic administration', 5)
('san', 8)
('t cells', 41)
('mediators', 2)
('lentivirus', 6)
('tdlns', 4)
('rat', 131)
('further', 18)
('cell surface', 4)
('pan02\xe2\x80\x9d', 4)
('thy1\\.1\\+', 4)
('organs', 2)
('cell types', 4)
('stromal', 2)
('il-12', 4)
('mechanism', 5)
('tumor inoculation', 4)
('note', 8)
('mix', 2)
('chemotaxis', 18)
('multiple', 4)
('normal', 26)
('buffer', 2)
('centrifugation', 2)
('most', 6)
('significant', 26)
('preliminary', 2)
('intrinsic', 4)
('probes', 6)
('ccr5 signaling', 12)
('flow', 8)
('disease', 6)
('inguinal lymph node', 8)
('pancreatic cancers', 4)
('sigma', 4)
('phenomenon', 6)
('probe', 6)
('cd25', 11)
('surgically', 8)
('malignant', 2)
('ipsilateral', 4)
('lethal', 4)
('line', 22)
('nln', 8)
('completion', 8)
('ratio', 61)
('knowledge', 2)
('receptors', 8)
('only', 14)
('\\/ml', 16)
('plate', 2)
('tak\\-779\\.', 6)
('hiv', 6)
('antagonism', 2)
('dependent', 9)
('overall', 4)
('cd4', 67)
('transduced', 6)
('breast', 4)
('cd8', 2)
('antagonist', 18)
('secondary', 4)
('rna expression', 2)
('organ', 8)
('tumors', 44)
('differential', 2)
('summary', 2)
('microscope', 4)
('experiments', 6)
('epcam', 14)
('cycles', 4)
('ficoll', 2)
('reference', 2)
('t cell subsets', 2)
('peripheral', 8)
('humans', 6)
('detection', 2)
('individual', 6)
('migration', 36)
('puromycin', 2)
('endothelial cells', 2)
('arm', 2)
('subject', 2)
('tumor microenvironment', 37)
('subsequent', 10)
('circulating', 4)
('sites', 8)
('3', 171)
('available', 2)
('statistically', 4)
('wa', 148)
('efficiency', 2)
('thy1', 10)
('reaction', 2)
('c', 3417)
('3\\+', 14)
('minutes', 6)
('cd25\\+', 7)
('5tmm', 2)
('ccr1', 4)
('ccr2', 2)
('ccr4', 6)
('ccr5', 227)
('context', 2)
('irradiated', 2)
('expression', 86)
('co', 272)
('cancer', 36)
('ccl5 production', 9)
('non', 32)
('66', 2)
('68', 2)
('panel', 2)
('ct', 276)
('targeting', 1)
('tdln', 20)
('intracellular', 4)
('splenic', 4)
('strategy', 3)
('reduction', 10)
('initiation', 4)
('1 mm', 2)
('interest', 2)
('cfse', 6)
('monoclonal', 2)
('5h', 2)
('cell fraction', 2)
('lymphoid', 4)
('al', 442)
('\\.', 465)
('ctcctggaagatggtgatgg', 3)
('representative', 4)
('demand', 2)
('receive', 2)
('ligands', 35)
('protocols', 4)
('malignancy\\.', 2)
('applied', 6)
('novel', 3)
('subsets', 2)
('frozen', 4)
('tumor-specific antigen', 2)
('collagen-induced', 2)
('healthy', 14)
('ongoing', 2)
('2\\+', 6)
('wild', 16)
('aid', 8)
('tumor specimens', 2)
('endothelial', 2)
('pancreatic adenocarcinoma', 59)
('concomitant', 2)
('prevalence', 45)
('thy1\\.2\\+', 6)
('site', 12)
('surface', 4)
('tissue', 30)
('left thigh', 2)
('spleens', 2)
('tumorigenesis', 2)
('protein', 4)
('mouse', 23)
('80\\%', 4)
('different', 12)
('baseline', 4)
('chemokine receptor', 11)
('administration', 11)
('cytometry', 8)
('same', 16)
('cd4\\+cd25\\+foxp3\\+', 1)
('plates', 2)
('mast cells', 2)
('tak-779', 41)
('development', 4)
('nih', 4)
('t reg', 2)
('effect', 33)
('kit', 2)
('levels', 9)
('quantitation', 2)
('immunofluorescence', 2)
('destruction', 1)
('metastatic tumor', 2)
('antibodies', 6)
('drain', 16)
('center', 2)
('reagent', 4)
('well', 6)
('myeloma', 2)
('analysis', 2)
('compartments', 28)
('chemokine', 34)
('materials', 1)
('model', 32)
('clearance', 2)
('disease progression', 2)
('protocol', 6)
('less', 2)
('effector', 7)
('50\\%', 4)
('human', 58)
('useful', 4)
('instance', 2)
('\\?', 63)
('ccr10', 2)
('niaid', 2)
('r\\.', 8)
('treatment', 23)
('lymphocytes', 16)
('\\/', 46)
('\\(', 260)
('\\)', 260)
('murine', 24)
('resections', 2)
('increased', 20)
('magnetic bead separation', 2)
('organ donation', 2)
('cd4\\+foxp3', 24)
('ccr5\\+\\.', 2)
('72 hours', 2)
('inhibition', 8)
('five', 2)
('pbmc', 4)
('intranuclear', 4)
('one week', 8)
('anti-rabbit', 2)
('malignancy', 4)
('51', 8)
('53', 4)
('parasite', 2)
('fibroblasts', 2)
('supernatant', 4)
('lymphocytic infiltration', 2)
('immunosuppressive', 4)
('t', 4762)
('dilution', 2)
('l-', 26)
('old', 14)
('methods', 5)
('sequence', 4)
('psicor-gfp', 4)
('cell line', 12)
('phosphoribosyl-transferase', 2)
('growth', 38)
('cxcl12', 2)
('breast carcinoma', 2)
('cxcr3', 6)
('flow cytometry', 8)
('dense', 4)
('resected', 18)
('4 weeks', 4)
('depletion', 4)
('inflammation', 6)
('gene expression', 14)
('cd11b', 2)
('either', 5)
('bd', 4)
('repository', 2)
('ccl17', 2)
('seconds', 2)
('10 minutes', 2)
('stem', 29)
('host', 2)
('fluorescent', 2)
('dct', 2)
('manufacturer', 8)
('tissue section', 4)
('tumor', 316)
('range', 8)
('systemic', 13)
('0\\.1mg\\/ml', 2)
('cancer stage', 2)
('histopaque', 4)
('curative', 2)
('antibody', 4)
('block', 23)
('software', 4)
('hpai', 2)
('presence', 8)
('hyaluronidase', 2)
('image', 6)
('washington', 6)
('functional', 6)
('negative', 8)
('anti-cd3', 4)
('receptor', 15)
('t cell migration', 6)
('cells\\.', 12)
('positive', 16)
('teff', 6)
('5 days', 4)
('vaccination', 2)
('hiv infection', 4)
('dnase', 2)
('adenocarcinoma', 61)
('low', 32)
('fraction', 2)
('secretion', 6)
('specimens', 16)
('function', 8)
('intratumoral', 4)
('medium', 2)
('complete', 8)
('secreted', 2)
('vehicle', 12)
('tumor-associated macrophage', 4)
('hypoxanthine-guanine', 2)
('mice', 87)
('myeloma cell', 2)
('4\\+', 51)
('type', 28)
('cells', 128)
('spleen', 26)
('vivo', 10)
('effector t cells', 5)
('rnai', 4)
('mouse model', 10)
('piece', 2)
('inoculation', 6)
('display', 4)
('bearing', 6)
('associated', 13)
('contralateral', 4)
('universal', 2)
('vcci', 2)
('slowing', 4)
('evidence', 4)
('single', 2)
('anti-cd3 antibody', 4)
('laboratory', 2)
('graft', 2)
('intact', 6)
('nm', 41)
('49', 10)
('control groups', 6)
('b16', 2)
('epcam-negative', 2)
('other', 56)
('5', 520)
('conclusion', 2)
('met', 23)
('viral', 16)
('models', 6)
('histopathologic type', 2)
('pan02', 79)
('important', 14)
('suppression', 4)
('\xe2\x80\x93', 38)
('mdsc', 4)
('30 minute', 2)
('kinetics', 4)
('immunocompetent', 4)
('mast', 4)
('time', 18)
('fresh', 4)
('cd4\\+\\ cd25\\+\\ regulatory\\ t\\ cells', 2)
('4c', 4)
